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Background
Abnormal protein expression of N-methyl-D-aspartate
(NMDA) receptors essential subunits (NR1, NR2) and
of associated post-synaptic density proteins (PSD-95,
PSD-93) were observed in schizophrenic patients (post-
mortem studies) [1,2]. NMDA receptors containing
NNR2A/B subunit associate in vivo at synapses with
PSD-93 and PSD-95 [3]. In the present study, we have
silenced the expression of NR1 and/or NR2 proteins in
vivo with the goal of assessing the influence of that pro-
tein’s alteration on the prepulse inhibition of acoustic star-
tle reaction (PPI) and on the expression of related
PSD-95/PSD-93 proteins.
Materials and methods
We used antisense oligodeoxynucleotide for NMDA-
NR1 individually or in combination with NR2A or
NR2B (aNR1, aNR2A, aNR2B) in the rat hippocampus
and evaluated the PPI. Western blot was employed to
assess the expression of affected proteins (NR1, NR2A
and NR2B) and associated PSD-95/93 proteins.
Results
Changes in expression of NR1 were found. We observed
a significant decrease in the hippocampi of rats affected
by the combination aNR2A/aNR2B when compared
with controls; yet we did not detect changes in other
applications. In addition, we found significant changes
in the expression of PSD-95, namely a decreased level of
this protein in groups treated with NR2A or NR2B.
There were no significant changes in NR2A/B and
PSD-93 expression and in PPI.
Conclusions
Despite the fact, that the short term silencing of NR1/
NR2 did not change PPI, there were changes in expres-
sion of PSD-95, which were connected with the NR2A/
B subunit whose protein expression was not changed.
This suggests that the association of PSD-95 with
NR2A/B may occur in the early phase of biosynthesis.
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